- EP Ablation Catheters
- EP Laboratory Devices
- EP Diagnostic Catheters
- Access Devices
Electrophysiology Devices Market size was valued at USD 3.41 billion in 2021 and expected to reach USD 6.52 billion in 2028 at a CAGR of 10.5% during the forecast period 2022-28. Electrophysiology Devices is a remote therapeutic gadget that utilizations high-recurrence sound waves to produce a picture of the bladder of the individual. The electrophysiology (EP) study aids in the evaluation of aberrant heartbeats as well as the examination of electrical impulses in the heart. Furthermore, significant advancements in electrophysiological technologies have enhanced the capacity to target the parts of the heart that cause atrial fibrillation (AF). Other cardiac arrhythmias, such as atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), atrial flutter, and others, have benefited from the advancements in technology. The electrophysiology devices market is strongly divided because of the nearness of a few global, local, and neighborhood merchants. The global players represent the real pieces of the pie by creating demonstrative EP gadgets and the provincial players create novel items that enhance procedure productivity, item viability, and patient solace. EP gadgets makers contend in view of forceful estimating, item affectability, item separation, and innovation overhauls. Expanded union among the sellers will strengthen the focused condition among the players in this market space. expanded pace of mechanical progressions in the field of electrophysiology and development sought after of EP gadgets for the treatment of cardiovascular arrhythmias is ready to help the EP showcase development at a twofold digit rate amid the estimate time frame.
Electrophysiology Devices Market Summary
Study Period
2023-29
Base Year
2022
CAGR
10.5%
Largest Market
North America
Fastest Growing Market
Europe
Electrophysiology Devices Market
Expanding utilization of electrophysiology gadgets in the finding and treatment of cardiovascular illnesses, for example, arrhythmias and atrial fibrillation and the developing worldwide geriatric populace base are some high effect rendering development drivers of the electrophysiology gadgets advertise. These objective illnesses have seen a fast development in frequency rates attributable to the developing predominance of infection causing way of life propensities, for example, smoking and unreasonable liquor utilization. Presentation of new advances, for example, cryo-removal, laser removal and ultrasound removal and propelled mapping innovations are likewise anticipated that would support the interest for electrophysiology gadgets throughout the following six years. In any case, high expenses related with electrophysiology gadgets, nearness of strict directions and accessibility of interchange treatments are a few variables anticipated that would obstruct advertise development.
North-America got significant share
Electrophysiology Devices Market
Geographically Electrophysiology Devices Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America leads global Electrophysiology Devices market due to growing awareness in early detection of cancer and prevalence of the breast cancer. Breast cancer.org estimated that in 2017, about 252,710 new invasive breast cancer and 63,410 new non- invasive breast cancer cases are expected to diagnosed in woman in U.S. Europe is expected to show notable growth rate owing to growing geriatric population and increase in adaptation of early diagnosis of breast cancer. Asia Pacific Electrophysiology Devices market is expected to grow at fastest rates owing to increasing prevalence of breast cancer and developing healthcare infrastructure
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Electrophysiology Devices Market Segmentation
By Product Type
by Indication
- Atrial Fibrillation
- Atrial Flutter
- Atrioventricular Nodal Reentry Tachycardia
- Wolff-Parkinson-White Syndrome
By End User
- Hospitals
- Diagnostic and Surgical Centers
- Ambulatory Care Centers
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Abbott Laboratories (U.S.)
- Biosense Webster, Inc. (U.S.)
- BIOTRONIK SE & Co. KG (Germany)
- Boston Scientific Corporation (U.S.)
- GE Healthcare (U.K.)
- Koninklijke Philips N.V. (The Netherlands)
- Medtronic, Inc. (U.S.)
- Microport Scientific Corporation (China)
- St. Jude Medical, Inc. (U.S.)
- Siemens AG (Germany)